artículo
Cost effectiveness of Daclatasvir/Asunaprevir versus Peginterferon/Ribavirin and protease inhibitors for the treatment of Hepatitis C genotype 1b naive patients in Chile
Fecha
2015Registro en:
10.1371/journal.pone.0141660
1932-6203
Autor
Vargas, Constanza L.
Espinoza Sepúlveda, Manuel Antonio
Giglio, Andres
Soza, Alejandro